Vitamin D and Prostate Health: Sunlight, Supplements & Cancer Risk

What is vitamin D?

Vitamin D is a fat-soluble vitamin that acts as a hormone in the body. It is produced in the skin when exposed to sunlight (UVB rays) and obtained from certain foods and supplements.

Vitamin D is essential for calcium absorption and bone health, but it also plays a role in cell growth, immune function, and inflammation – all relevant to cancer development.

Vitamin D and prostate cancer risk – what the research shows

The relationship between vitamin D and prostate cancer is complex and controversial.

Observational studies (epidemiology):

• Ecological studies: Higher prostate cancer rates in northern latitudes (less sunlight) – suggests protective effect.
• Individual studies: Mixed results – some show lower risk with higher vitamin D, others show no association or even increased risk.
• Meta-analyses: No clear association between vitamin D levels and prostate cancer risk.

Mendelian randomisation studies (genetic evidence):

• Studies using genetic variants that affect vitamin D levels show no causal relationship between vitamin D and prostate cancer risk.
• This suggests observational findings may be confounded by other factors.

U-shaped curve hypothesis:

• Some studies suggest both low AND very high vitamin D levels may increase risk
• Optimal range may be 30-50 ng/mL

Vitamin D deficiency – common in prostate cancer patients

Vitamin D deficiency is very common in men with prostate cancer:

• Prevalence: 50-70% of men with prostate cancer have low vitamin D (<20 ng/mL)
• Causes: Older age, less sunlight exposure, darker skin, obesity, treatment-related (ADT)
• Association with aggressive disease: Some studies link deficiency to higher Gleason score and worse outcomes

Recommendation:

• All men with prostate cancer should have their vitamin D level checked
• Correct deficiency with supplements (not for cancer treatment, but for bone health)

Optimal blood levels – 30-50 ng/mL

Vitamin D levels are measured as 25-hydroxyvitamin D [25(OH)D] in ng/mL or nmol/L.

• Deficient: <20 ng/mL (<50 nmol/L)
• Insufficient: 20-30 ng/mL (50-75 nmol/L)
• Sufficient: 30-50 ng/mL (75-125 nmol/L)
• High (potential toxicity): >100 ng/mL (>250 nmol/L)

Target for prostate health:

• Aim for 30-50 ng/mL – sufficient for bone health and general wellness
• No evidence that higher levels (>50 ng/mL) provide additional prostate cancer benefit

Sunlight exposure – benefits and skin cancer risk

Sunlight is the primary source of vitamin D for most people.

Benefits:

• 10-30 minutes of midday sun (face, arms, legs) 2-3 times/week can maintain adequate levels
• No sunscreen during this short exposure (but apply after)

Risks:

• Skin cancer (melanoma, squamous cell, basal cell)
• Premature skin aging

Recommendation:

• Balance: short sun exposure for vitamin D, then sunscreen
• For most people, supplements are safer and more reliable than sun exposure
• People with history of skin cancer should avoid sun exposure and use supplements

Supplementation – dosing, safety, upper limit

Vitamin D supplements are safe and effective for correcting deficiency.

Recommended daily intake (IOM):

• Age 1-70: 600 IU/day
• Age 70+: 800 IU/day

For deficiency (clinical practice):

• Mild deficiency (20-30 ng/mL): 1,000-2,000 IU/day
• Moderate deficiency (10-20 ng/mL): 2,000-4,000 IU/day
• Severe deficiency (<10 ng/mL): 50,000 IU once weekly for 8 weeks, then maintenance

Safety:

• Upper limit (safe): 4,000 IU/day for most adults
• Toxicity risk >10,000 IU/day (causes hypercalcemia, kidney stones)

Vitamin D for BPH – limited evidence

Evidence for vitamin D in BPH (enlarged prostate) is very limited:

• Some small studies suggest vitamin D deficiency may be associated with larger prostate size
• No clinical trials show that vitamin D supplementation improves BPH symptoms
• Not recommended for BPH treatment

Drug interactions – thiazide diuretics, steroids

Vitamin D supplements can interact with certain medications:

• Thiazide diuretics (HCTZ, chlorthalidone): Increase calcium absorption – risk of hypercalcemia. Monitor calcium levels.
• Corticosteroids (prednisone): Reduce calcium absorption – may need higher vitamin D doses.
• Orlistat (weight loss), cholestyramine (cholesterol): Reduce vitamin D absorption – take at different times.
• Phenytoin, phenobarbital (seizure meds): Increase vitamin D breakdown – may need higher doses.

Interactive FAQ – Vitamin D and prostate health

---

Disclaimer: This information is for educational purposes. Vitamin D supplementation should be guided by blood testing. Consult a urologist at Vivekananda Hospital for personalised advice.